Clinical Trials Browser

dostarlimab × Other solid neoplasm × 1 year × Clear all

NCT07013851 2025-06-10

NADIA

Phase 2 Not yet recruiting

GynecologicOther solid neoplasm

MMRd/MSI-H Stage II-III Endometrial Cancer